The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gonadorelin for Injection Market Research Report 2025
Synopsis
The indications for gonadorelin for injection are that this product is suitable for the differential diagnosis of male or female fertility disorders caused by hypothalamic or pituitary hypofunction, gonadal atrophic hypogonadism, galactorrhea amenorrhea, primary and secondary Sexual amenorrhea, menopause and precocious menopause, pituitary tumors, organ damage to the pituitary gland, and de facto hypothalamic dysfunction.
Global Gonadorelin for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gonadorelin for Injection market research.
Key manufacturers engaged in the Gonadorelin for Injection industry include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON and Ipsen, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Gonadorelin for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gonadorelin for Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gonadorelin for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Astellas Pharma
Takeda
LIVZON
Ipsen
Sanofi
Endo
Tocris Bioscience
Sigma-Aldrich
MedChem Express
Arbor Pharmaceuticals
ESTEVE
Anhui Fengyuan Pharmaceutical
Segment by Type
100μg/ml
200μg/ml
300μg/ml
400μg/ml
500μg/ml
Others
Segment by Application
Patients With Fertility Disorders
Patients With Endocrine Disorders
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gonadorelin for Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The indications for gonadorelin for injection are that this product is suitable for the differential diagnosis of male or female fertility disorders caused by hypothalamic or pituitary hypofunction, gonadal atrophic hypogonadism, galactorrhea amenorrhea, primary and secondary Sexual amenorrhea, menopause and precocious menopause, pituitary tumors, organ damage to the pituitary gland, and de facto hypothalamic dysfunction.
Global Gonadorelin for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gonadorelin for Injection market research.
Key manufacturers engaged in the Gonadorelin for Injection industry include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON and Ipsen, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Gonadorelin for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gonadorelin for Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gonadorelin for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Astellas Pharma
Takeda
LIVZON
Ipsen
Sanofi
Endo
Tocris Bioscience
Sigma-Aldrich
MedChem Express
Arbor Pharmaceuticals
ESTEVE
Anhui Fengyuan Pharmaceutical
Segment by Type
100μg/ml
200μg/ml
300μg/ml
400μg/ml
500μg/ml
Others
Segment by Application
Patients With Fertility Disorders
Patients With Endocrine Disorders
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gonadorelin for Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Gonadorelin for Injection Market Overview
1.1 Product Overview and Scope of Gonadorelin for Injection
1.2 Gonadorelin for Injection Segment by Type
1.2.1 Global Gonadorelin for Injection Market Value Comparison by Type (2023-2029)
1.2.2 100μg/ml
1.2.3 200μg/ml
1.2.4 300μg/ml
1.2.5 400μg/ml
1.2.6 500μg/ml
1.2.7 Others
1.3 Gonadorelin for Injection Segment by Application
1.3.1 Global Gonadorelin for Injection Market Value by Application: (2023-2029)
1.3.2 Patients With Fertility Disorders
1.3.3 Patients With Endocrine Disorders
1.3.4 Others
1.4 Global Gonadorelin for Injection Market Size Estimates and Forecasts
1.4.1 Global Gonadorelin for Injection Revenue 2018-2029
1.4.2 Global Gonadorelin for Injection Sales 2018-2029
1.4.3 Global Gonadorelin for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gonadorelin for Injection Market Competition by Manufacturers
2.1 Global Gonadorelin for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gonadorelin for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gonadorelin for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Gonadorelin for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gonadorelin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadorelin for Injection, Product Type & Application
2.7 Gonadorelin for Injection Market Competitive Situation and Trends
2.7.1 Gonadorelin for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gonadorelin for Injection Players Market Share by Revenue
2.7.3 Global Gonadorelin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gonadorelin for Injection Retrospective Market Scenario by Region
3.1 Global Gonadorelin for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gonadorelin for Injection Global Gonadorelin for Injection Sales by Region: 2018-2029
3.2.1 Global Gonadorelin for Injection Sales by Region: 2018-2023
3.2.2 Global Gonadorelin for Injection Sales by Region: 2024-2029
3.3 Global Gonadorelin for Injection Global Gonadorelin for Injection Revenue by Region: 2018-2029
3.3.1 Global Gonadorelin for Injection Revenue by Region: 2018-2023
3.3.2 Global Gonadorelin for Injection Revenue by Region: 2024-2029
3.4 North America Gonadorelin for Injection Market Facts & Figures by Country
3.4.1 North America Gonadorelin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gonadorelin for Injection Sales by Country (2018-2029)
3.4.3 North America Gonadorelin for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadorelin for Injection Market Facts & Figures by Country
3.5.1 Europe Gonadorelin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gonadorelin for Injection Sales by Country (2018-2029)
3.5.3 Europe Gonadorelin for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadorelin for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Gonadorelin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gonadorelin for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Gonadorelin for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gonadorelin for Injection Market Facts & Figures by Country
3.7.1 Latin America Gonadorelin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gonadorelin for Injection Sales by Country (2018-2029)
3.7.3 Latin America Gonadorelin for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Gonadorelin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadorelin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gonadorelin for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gonadorelin for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gonadorelin for Injection Sales by Type (2018-2029)
4.1.1 Global Gonadorelin for Injection Sales by Type (2018-2023)
4.1.2 Global Gonadorelin for Injection Sales by Type (2024-2029)
4.1.3 Global Gonadorelin for Injection Sales Market Share by Type (2018-2029)
4.2 Global Gonadorelin for Injection Revenue by Type (2018-2029)
4.2.1 Global Gonadorelin for Injection Revenue by Type (2018-2023)
4.2.2 Global Gonadorelin for Injection Revenue by Type (2024-2029)
4.2.3 Global Gonadorelin for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Gonadorelin for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gonadorelin for Injection Sales by Application (2018-2029)
5.1.1 Global Gonadorelin for Injection Sales by Application (2018-2023)
5.1.2 Global Gonadorelin for Injection Sales by Application (2024-2029)
5.1.3 Global Gonadorelin for Injection Sales Market Share by Application (2018-2029)
5.2 Global Gonadorelin for Injection Revenue by Application (2018-2029)
5.2.1 Global Gonadorelin for Injection Revenue by Application (2018-2023)
5.2.2 Global Gonadorelin for Injection Revenue by Application (2024-2029)
5.2.3 Global Gonadorelin for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Gonadorelin for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Gonadorelin for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AbbVie Gonadorelin for Injection Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AstraZeneca Gonadorelin for Injection Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Ferring
6.4.1 Ferring Corporation Information
6.4.2 Ferring Description and Business Overview
6.4.3 Ferring Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ferring Gonadorelin for Injection Product Portfolio
6.4.5 Ferring Recent Developments/Updates
6.5 TerSera Therapeutics
6.5.1 TerSera Therapeutics Corporation Information
6.5.2 TerSera Therapeutics Description and Business Overview
6.5.3 TerSera Therapeutics Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TerSera Therapeutics Gonadorelin for Injection Product Portfolio
6.5.5 TerSera Therapeutics Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Astellas Pharma Gonadorelin for Injection Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 Takeda
6.6.1 Takeda Corporation Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda Gonadorelin for Injection Product Portfolio
6.7.5 Takeda Recent Developments/Updates
6.8 LIVZON
6.8.1 LIVZON Corporation Information
6.8.2 LIVZON Description and Business Overview
6.8.3 LIVZON Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 LIVZON Gonadorelin for Injection Product Portfolio
6.8.5 LIVZON Recent Developments/Updates
6.9 Ipsen
6.9.1 Ipsen Corporation Information
6.9.2 Ipsen Description and Business Overview
6.9.3 Ipsen Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ipsen Gonadorelin for Injection Product Portfolio
6.9.5 Ipsen Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sanofi Gonadorelin for Injection Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Endo
6.11.1 Endo Corporation Information
6.11.2 Endo Gonadorelin for Injection Description and Business Overview
6.11.3 Endo Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Endo Gonadorelin for Injection Product Portfolio
6.11.5 Endo Recent Developments/Updates
6.12 Tocris Bioscience
6.12.1 Tocris Bioscience Corporation Information
6.12.2 Tocris Bioscience Gonadorelin for Injection Description and Business Overview
6.12.3 Tocris Bioscience Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tocris Bioscience Gonadorelin for Injection Product Portfolio
6.12.5 Tocris Bioscience Recent Developments/Updates
6.13 Sigma-Aldrich
6.13.1 Sigma-Aldrich Corporation Information
6.13.2 Sigma-Aldrich Gonadorelin for Injection Description and Business Overview
6.13.3 Sigma-Aldrich Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sigma-Aldrich Gonadorelin for Injection Product Portfolio
6.13.5 Sigma-Aldrich Recent Developments/Updates
6.14 MedChem Express
6.14.1 MedChem Express Corporation Information
6.14.2 MedChem Express Gonadorelin for Injection Description and Business Overview
6.14.3 MedChem Express Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MedChem Express Gonadorelin for Injection Product Portfolio
6.14.5 MedChem Express Recent Developments/Updates
6.15 Arbor Pharmaceuticals
6.15.1 Arbor Pharmaceuticals Corporation Information
6.15.2 Arbor Pharmaceuticals Gonadorelin for Injection Description and Business Overview
6.15.3 Arbor Pharmaceuticals Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Arbor Pharmaceuticals Gonadorelin for Injection Product Portfolio
6.15.5 Arbor Pharmaceuticals Recent Developments/Updates
6.16 ESTEVE
6.16.1 ESTEVE Corporation Information
6.16.2 ESTEVE Gonadorelin for Injection Description and Business Overview
6.16.3 ESTEVE Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ESTEVE Gonadorelin for Injection Product Portfolio
6.16.5 ESTEVE Recent Developments/Updates
6.17 Anhui Fengyuan Pharmaceutical
6.17.1 Anhui Fengyuan Pharmaceutical Corporation Information
6.17.2 Anhui Fengyuan Pharmaceutical Gonadorelin for Injection Description and Business Overview
6.17.3 Anhui Fengyuan Pharmaceutical Gonadorelin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Anhui Fengyuan Pharmaceutical Gonadorelin for Injection Product Portfolio
6.17.5 Anhui Fengyuan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gonadorelin for Injection Industry Chain Analysis
7.2 Gonadorelin for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadorelin for Injection Production Mode & Process
7.4 Gonadorelin for Injection Sales and Marketing
7.4.1 Gonadorelin for Injection Sales Channels
7.4.2 Gonadorelin for Injection Distributors
7.5 Gonadorelin for Injection Customers
8 Gonadorelin for Injection Market Dynamics
8.1 Gonadorelin for Injection Industry Trends
8.2 Gonadorelin for Injection Market Drivers
8.3 Gonadorelin for Injection Market Challenges
8.4 Gonadorelin for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
